未登录.png)
分享.png)
收藏The cell cycle regulator PLK1 promotes murine melanoma progression by regulating the transcription factor BACH1
Mao, Fengyi; Wu, Sai; Allison, Derek B.; He, Daheng; Kong, Yifan; Li, Chaohao; Li, Zhiguo; Zhang, Yanquan; Wang, Xinyi; Zhang, Qiongsi; Wang, Chi; Liu, Xiaoqi 分享 收藏 分享 收藏 分享 收藏 Artesunate enhances the efficacy of enzalutamide in advanced prostate cancer阿托斯酸增强恩扎卢胺在晚期前列腺癌中的疗效Wang, Xinyi; Liu, Jinghui; Mao, Fengyi; Kong, Yifan; Zhang, Qiongsi; Li, Chaohao; He, Daheng; Wang, Chi; Zhang, Yanquan; Wang, Ruixin; Ellingson, Sally R.; Wei, Qiou; Li, Zhiguo 分享 收藏 Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosisZhang, Yanquan; Fong, Ka-Wing; Mao, Fengyi; Wang, Ruixin; Allison, Derek B.; Napier, Dana; He, Daheng; Liu, Jinpeng; Zhang, Yeqing; Chen, Jing; Kong, Yifan; Li, Chaohao; Li, Guangbing; Liu, Jinghui; Li, Zhiguo; Zhu, Haining; Wang, Chi; Liu, Xiaoqi 分享 收藏 Single-cell analysis identifies PLK1 as a driver of immunosuppressive tumor microenvironment in LUADKong, Yifan; Li, Chaohao; Liu, Jinpeng; Wu, Sai; Zhang, Min; Allison, Derek B.; Hassan, Faisal; He, Daheng; Wang, Xinyi; Mao, Fengyi; Zhang, Qiongsi; Zhang, Yanquan; Li, Zhiguo; Wang, Chi; Liu, Xiaoqi 分享 收藏 分享 收藏 PLK1-dependent phosphorylation of PRMT5 promotes DNA damage response in prostate cancerPeng, Jia; Zhang, Yanquan; Wang, Jianlin; Li, Qianjin; He, Daheng; Wang, Xinyi; Rao, Xiongjian; Wu, Meng; Mo, Pingli; Wang, Lei; Wu, Sai; Wang, Ruixin; Liu, Jinghui; Nouri, Mansoureh; Tadahide, Izumi; Liu, Xiaoqi 分享 收藏 分享 收藏 Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via DIO2-TH signalingLi, Chaohao; Allison, Derek B.; He, Daheng; Mao, Fengyi; Wang, Xinyi; Rychahou, Piotr; Imam, Ibrahim A.; Kong, Yifan; Zhang, Qiongsi; Zhang, Yanquan; Liu, Jinghui; Wang, Ruixin; Rao, Xiongjian; Wu, Sai; Evers, B. Mark; Shao, Qing; Wang, Chi; Li, Zhiguo; Liu, Xiaoqi 分享 收藏 分享 收藏 Taxol-elevated PLK1 overcomes BETi-resistant in prostate cancer via triggering phosphorylation-dependent degradation of BRD4Zhang, Yanquan; Fong, Ka Will; Mao, Fengyi; Wang, Ruixin; Kong, Yifan; Li, Chaohao; Liu, Jinghui; Li, Zhiguo; Allison, Derek B.; Napier, Dana; Li, Daheng; Liu, Jinpeng; Wang, Chi; Zhang, Yeqing; Li, Guangbing; Liu, Xiaoqi 分享 收藏 Phosphorylation of AHR by PLK1 promotes metastasis of LUAD via upregulation of DIO2Li, Chaohao; He, Daheng; Mao, Fengyi; Wang, Xinyi; Hao, Yanning; Kong, Yifan; Brainson, Christine F.; Liu, Jinghui; Zhang, Yanquan; Wang, Ruixin; Zhang, Qiongsi; Li, Zhiguo; Rao, Xiongjian; Wu, Sai; Wang, Chi; Wei, Qiou; Wang, Jianlin; Liu, Xiaoqi 分享 收藏 分享 收藏 A kinome-wide CRISPR screen identifies CK1a as a target to overcome enzalutamide resistance of prostate cancerLiu, Jinghui; Zhao, Yue; He, Daheng; Jones, Katelyn M.; Tang, Shan; Allison, Derek B.; Zhang, Yanquan; Chen, Jing; Zhang, Qiongsi; Wang, Xinyi; Li, Chaohao; Wang, Chi; Li, Lang; Liu, Xiaoqi 分享 收藏 分享 收藏 The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RETKong, Yifan; Allison, Derek B.; Zhang, Qiongsi; He, Daheng; Li, Yuntong; Mao, Fengyi; Li, Chaohao; Li, Zhiguo; Zhang, Yanquan; Wang, Jianlin; Wang, Chi; Brainson, Christine F.; Liu, Xiaoqi 分享 收藏 GSTM2 is a key molecular determinant of resistance to SG-ARIsLi, Chaohao; Liu, Jinpeng; He, Daheng; Mao, Fengyi; Rao, Xiongjian; Zhao, Yue; Lanman, Nadia A.; Kazemian, Majid; Farah, Elia; Liu, Jinghui; Ngule, Chrispus M.; Zhang, Zhuangzhuang; Zhang, Yanquan; Kong, Yifan; Li, Lang; Wang, Chi; Liu, Xiaoqi 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
